皮膚科王修含醫師: 【王修含醫師演講公告】使用多種色素與血管雷射治療肝斑-2015 Candela APAC User Meeting

【王修含醫師演講公告】
研討會名稱：2015 Candela APAC User Meeting (會議語言：英語)
演講題目：Treatment of melasma with multiple pigment and vascular lasers (使用多種色素與血管雷射治療肝斑)
講師：皮膚科王修含醫師
演講日期：2015年7月19日(星期日) 下午 15:40-16:10
演講地點：台北國際會議中心102會議室
地址：台北市信義區信義路五段1號
主辦單位：Candela-Syneron ® Medical Ltd.、曜亞國際Dynamic Medical Technologies Inc.

【本站文章版權所有，歡迎非商業性「部份」轉載（請勿全文轉載），轉載請註明作者姓名標示(皮膚科王修含醫師)與出處(skin168.net/ skin168.com/ skin168.org)，禁止更動內文，並提供有效的本站超連結。】

親愛的醫師您好：
感謝您對Candela的多年支持，奠定了Candela全球醫美儀器市場領導品牌地位，現在每年全球已經有1000多萬人次選擇Candela儀器進行治療。2015 Candela APAC User Meeting定於2015年7月19日，假台北國際會議中心102會議室盛大舉行，並授權由台灣代理商曜亞國際擔任主辦商，本次邀請多位來自亞洲各地國際重量級講師，針對Gentle Series、VBEAM等儀器使用作深入研討，並介紹全球最新醫美趨勢Picoway雙波皮秒雷射，邀請您蒞臨參與台灣醫學美容美與國際接軌的時刻。

2015 APAC Candela User Meeting

Agenda

Time	Topic	Speaker
09:00-09:20	Admission
09:20-09:30	Opening	Justin Jen
09:30-09:50	Candela: Past, Present and Future	Robert Ruck
Moderator: Chung-Jen Tseng, MD
09:50-10:30	The Use of Dual 532/1064nm Wavelength Picosecond Laser in Asians.	Henry CHAN, MD
10:30-10:50	Coffee Break
10:50-11:30	The Next Generation of the Short-Pulsed Laser, "Picoway, the Shortest Pico Laser.	Taro KONO, MD
11:30-11:50	Panel Discussion
11:50-13:00	Lunch Break (4F VIP Room)
Moderator: Hsien-Li Peng, MD
13:00-13:30	Combined Long-Pulsed Dye 595 and Long-Pulsed Alexandrite 755nm Laser for the Treatment of Vascular Lesion	Henry CHAN, MD
13:30-14:00	My Strategy in Using "GentleMax Pro" of Melasma & Other Pigmented Lesions or Vascular Lesion Treatments.	Geun-Soo LEE, MD
14:00-14:30	Innovative “MelaToning” Therapy for Melasma and Pigmentation with Candela GentleLASE ProU System.	Sindy HU, MD
14:30-14:50	Panel Discussion
14:50-15:10	Coffee Break
Moderator: Cheng-Jen Chang, MD
15:10-15:40	The Unique Features and Expanding Dermatology Indications for the VBeam Perfecta Pulsed Dye Laser.	Chee-Leok GOH, MD
15:40-16:10	Treatment of Melasma with Multiple Pigment and Vascular Lasers.	Shiou-Han WANG, MD
16:10-16:40	Applications of VBeam on Non-vascular related Skin Lesions	Woraphong Manuskiati, MD
16:40-17:00	Panel Discussion
17:00-17:15	Closing Meeting	Candela/DMT

Notice for speakers

1. You are welcomed to arrive TICC (Room 102) in the beginning or arrive during the break before your product group session to test your presentation file.

2. Please control your presentation time according to the program. A reminder bell will be sounded as a signal for you to wrap up your presentation within the next 5 minutes, it will be sounded again when time is up, and again when it’s over 5 minutes.

3. Please prepare one sentence about your image of Candela, we will have a short video shooting during breaks.

Notice for moderators

1. Please come to the stage and introduce speakers before their speech.

2. Please control Q&A time according to the program. A reminder bell will be sounded as a signal when time is up, and it will be sounded twice again when it is over 5 minutes.

3. Please prepare one sentence about your image of Candela, we will have a short video shooting during breaks.

Treatment of melasma with multiple pigment and vascular lasers

Shiou-Han Wang(王修含), MD, MSEE

Department of Dermatology, National Taiwan University Hospital (台大醫院皮膚部)

Skin168 Institute of Dermatology(王修含皮膚科診所)

There is a great deal of general literature on the study of melasma (chloasma). These results suggest that melasma has many triggering factors, such as chronic sun exposure, sexual hormone, inflammation, cosmetics, photosensitive agents, psychotropics, anxiety and genetic predisposition.

Owing to the pigmentary nature of melasma, low-fluence Q-switched (QS) neodymium-doped yttrium-aluminum-garnet (Nd: YAG) 1,064-nm laser has been shown effective at improving melasma. Low-fluence QS alexandrite laser also contributes to the improvement of melasma. Long-pulsed alexandrite laser (LPA) can be used for freckles & lentigines with quick and effective response. Compared with QS alexandrite laser, LPA has a lower risk of adverse effects for darker skin types, and can be applied for the scenario of melasma.

Recent histopathologic research has suggested that vascular abnormalities are related to the pathogenesis of melasma. Many cutaneous vascular lesions, including melasma can be treated successfully with the pulsed dye laser (PDL). The therapeutical effect of PDL has been proved for traditional conditions mostly composed of vascular lesions, including hemangioma, vascular malformations/ port-wine stain, rosacea, telangiectasia, spider veins of lower limbs, ecchymoses after facial cosmetic procedures. Some cutaneous disorders with abundant vascularity also respond to PDL, such as hypertrophic scar, keloid, verruca vulgaris and psoriasis. However, the PDL is applicable for many clinical scenarios far beyond the mentioned traditional conditions.

The new generation, long pulse duration, pulsed-dye laser (LPDL) VBeam II can be used for traditional indications and novel pathological/aesthetic applications. LPDL is showed useful for skin rejuvenation and photodamaged skin with superior effect to intense pulsed light (IPL). With special technique, LPDL can treat pigmentary diseases, such as lentigines and melasma.

To conclude, recent studies revealed the pigmentary and vascular characteristics of melamsa and it can be managed with combined therapy of LPDL, QS Nd:YAG laser and LPA laser. However, adequate parameters and techniques should be well applied because inflammation may contribute to the worsening of melasma.